Hyderabad, 17th May 2021: Apollo Hospitals (Apollo), Asia’s foremost integrated healthcare services provider, and Dr. Reddy’s Laboratories (Dr. Reddy’s), a leading Indian multinational pharmaceutical company today announced the launch of a limited pilot program for the Sputnik V vaccine as part of the soft launch by Dr. Reddy’s in India. The first phase of the program will kick off with vaccinations in Hyderabad on Monday (May 17, 2021) and in Visakhapatnam on Tuesday (May 18, 2021) at separate facilities at the Apollo Hospitals in those cities.

Apollo Hospitals Group is launching the Billion Hearts Beating (BHB), the cardiac awareness campaign with Times of India from 28th of April, 2010. This campaign has been developed in partnership with Times of India, to create awareness and a mass movement in the country towards people taking control of their heart and health. This campaign comes from Apollo, as a responsible global healthcare group and intends to educate the people about heart problems and the main 7 risk factors which people need to know, as Chairman always emphasizes. More importantly it also urges for an action, i.e.

Hyderabad, 15th February 2021: The Heart transplant per

Apollo Hospitals Ahmedabad situated at Bhat GIDC, has become one of the largest privately held critical care centres in Gujarat with the recent addition of an 11 bedded state-of-the-art Intensive Care Unit (ICU) to its current facilities, taking their total critical care bed capacity to 87. With this Apollo brings in a new dawn in Critical Care Medicine with a bed mix of 31% ICU beds as opposed to the general norm of 10-15%. This is an initiative towards positioning the Indian critical care services at par with the level International standards aspire to achieve.

Cancer Awareness Program Organised At Apollo Proton Can

Hyderabad, December 2020: The team of Cardiologists at Apollo Hospitals, led by Dr. A. Sreenivas Kumar, Director, Cardiology & Clinical Research; performed a critical cardiac procedure – ‘Trans Aortic Valve Replacement’ (TAVR) on an 83-year-old COVID survivor male patient from West Godavari District, suffering from Hypertension, Mild Coronary Artery Disease, COPD, severe Degenerative Aortic Valve Disease, severe Aortic Stenosis and Mild Aortic Regurgitation.

Apollo Proton Cancer Centre (APCC) has launched the Apollo Rectal Cancer (ARC) Programme – India’s pioneering approach dedicated to rectal cancer management. With a focus on rectal preservation and powered by advanced technologies including chemoradiotherapy, proton therapy, and robotic surgery, the ARC programme aims to revolutionize the treatment of rectal cancer in the country. This unique initiative addresses the specialized needs of rectal cancer patients, providing comprehensive and multidisciplinary care to ensure the best possible outcomes.